全文获取类型
收费全文 | 134750篇 |
免费 | 7713篇 |
国内免费 | 104篇 |
专业分类
耳鼻咽喉 | 1624篇 |
儿科学 | 5142篇 |
妇产科学 | 3945篇 |
基础医学 | 16272篇 |
口腔科学 | 3137篇 |
临床医学 | 16318篇 |
内科学 | 24230篇 |
皮肤病学 | 1655篇 |
神经病学 | 12691篇 |
特种医学 | 6422篇 |
外科学 | 21827篇 |
综合类 | 676篇 |
一般理论 | 55篇 |
预防医学 | 11873篇 |
眼科学 | 2158篇 |
药学 | 6117篇 |
1篇 | |
中国医学 | 64篇 |
肿瘤学 | 8360篇 |
出版年
2023年 | 3764篇 |
2022年 | 5671篇 |
2021年 | 5913篇 |
2020年 | 6256篇 |
2019年 | 4227篇 |
2018年 | 4267篇 |
2017年 | 4104篇 |
2016年 | 4059篇 |
2015年 | 4086篇 |
2014年 | 7299篇 |
2013年 | 6672篇 |
2012年 | 5218篇 |
2011年 | 5109篇 |
2010年 | 5182篇 |
2009年 | 4917篇 |
2008年 | 4444篇 |
2007年 | 4628篇 |
2006年 | 4434篇 |
2005年 | 4124篇 |
2004年 | 3757篇 |
2003年 | 3874篇 |
2002年 | 3577篇 |
2001年 | 3471篇 |
2000年 | 3404篇 |
1999年 | 3339篇 |
1998年 | 1415篇 |
1997年 | 1204篇 |
1996年 | 1207篇 |
1995年 | 1129篇 |
1994年 | 945篇 |
1993年 | 799篇 |
1992年 | 2489篇 |
1991年 | 2289篇 |
1990年 | 2248篇 |
1989年 | 2156篇 |
1988年 | 1957篇 |
1987年 | 966篇 |
1986年 | 465篇 |
1985年 | 628篇 |
1984年 | 586篇 |
1983年 | 533篇 |
1982年 | 585篇 |
1981年 | 538篇 |
1980年 | 531篇 |
1979年 | 497篇 |
1978年 | 473篇 |
1977年 | 380篇 |
1976年 | 377篇 |
1975年 | 325篇 |
1974年 | 396篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
《Neuromuscular disorders : NMD》2022,32(1):25-32
Autoantibodies against 3?hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and the signal recognition particle (SRP) are representative antibodies causing immune-mediated necrotizing myopathies (IMNM), called as anti-HMGCR and anti-SRP myopathies, respectively. Here, we analyzed the differences in routine blood test results between 56 anti-HMGCR and 77 anti-SRP myopathy patients. A higher alanine transaminase (ALT) level and a lower aspartate transaminase (AST)/ALT ratio were observed in anti-HMGCR myopathy patients [ALT, 265.7 ± 213.3 U/L (mean ± standard deviation); AST/ALT ratio, 0.88 ± 0.32] than in anti-SRP-myopathy patients (ALT, 179.3 ± 111.2 U/L, p < 0.05; AST/ALT ratio, 1.28 ± 0.40, p < 0.01). In the active phase, anti-HMGCR myopathy often showed ALT predominance, whereas anti-SRP myopathy often showed AST predominance. In addition, there were differences in erythrocyte sedimentation rate (ESR), total cholesterol (TChol) level, and high-density lipoprotein (HDL) level between anti-HMGCR and anti-SRP myopathies (ESR: HMGCR, 24.4 ± 20.8 mm/1 h; SRP, 35.7 ± 26.7 mm/1 h, p = 0.0334; TChol: HMGCR, 226.7 ± 36.6 mg/dL; SRP, 207.6 ± 40.8 mg/dL, p = 0.0163; HDL: HMGCR, 58.4 ± 13.9 mg/dL; SRP, 46.2 ± 17.3 mg/dL, p < 0.01). Additional studies on the differences in routine blood test results may further reveal the pathomechanisms of IMNM. 相似文献
32.
33.
34.
Journal of Behavioral Medicine - Evidence supports the use of graphic warnings to educate the public about the health harms of smoking and suggests warnings eliciting negative emotional responses... 相似文献
35.
36.
37.
Provisional single drug-eluting stent (DES) strategy remains the standard of care in simple bifurcation lesions which comprise the vast majority of coronary bifurcations. Nevertheless, the presence of complex bifurcations which are defined based on the 1) Side Branch (SB) lesion length of >10 mm and 2) SB ostial diameter stenosis of >70% are approached with a 2-DES strategy upfront. The bifurcation angle will further define the most appropriate technique, with T-stenting more suitable in angulations close to 90°, Culotte and the family of Crush techniques more appropriate for acute angles of <75°. The Crush techniques which are composed of the classic Crush, mini-Crush and double kissing Crush (DK-Crush) share the core principle of protruding the SB DES within the Main Branch (MB) to minimize the risk of ostial SB restenosis, which remains the most prevalent etiology of stent failure during 2-stent approach in bifurcations. Proximal Side Optimization (PSO) is an additional technical consideration to further optimize the protruding SB struts enabling 1) optimal SB strut accommodation to the larger MB vessel diameter, 2) strut enlargement that will further facilitate effortless rewiring for kissing balloon inflation (KBI) avoiding unfavorable guide wire advancement in the peri-ostial SB area. 相似文献
38.
39.
《Journal of clinical lipidology》2021,15(4):540-544
Cerebrotendinous xanthomatosis (CTX), sitosterolemia, and Smith-Lemli Opitz syndrome (SLOS) are rare inborn errors of metabolism. The diagnoses of CTX and sitosterolemia are often delayed for many years because of lack of physician awareness, often resulting in significant and unnecessary progression of disease. CTX may present with chronic diarrhea, juvenile onset cataracts, strikingly large xanthomas, and neurologic disease in the setting of a normal serum cholesterol, but markedly elevated serum or plasma cholestanol levels. These patients have a defect in producing the bile acid chenodoxycholate, and oral chenodeoxycholate therapy is essential for these patients in order to prevent neurologic complications. Sitosterolemia can present with xanthomas, anemia, thrombocytopenia, splenomegaly, very premature heart disease, and serum cholesterol levels that may be normal or elevated, along with marked elevations of plasma β-sitosterol. These patients have a defect causing overabsorption of β-sitosterol, and the treatment of choice is oral ezetimibe. SLOS presents with growth delay, intellectual disability, multiple structural anomalies, and low serum cholesterol levels, and the defect is reduced cholesterol production. Treatment consists of dietary cholesterol supplementation and oral bile acid therapy which raises serum cholesterol levels and may improve symptoms. The metabolic and genetic defects in these disorders have been defined. There is no one in our field that has contributed more to the diagnosis and treatment of these disorders than Gerald Salen, MD, who died in late 2020 at 85 years of age. He will be greatly missed by his family, friends, and colleagues from around the world. 相似文献
40.